Best Grants for Cancer Nonprofits in Wisconsin

The Cancer Center Support Grants (CCSGs) aim to bolster NCI-Designated Cancer Centers by funding comprehensive, clinical, and basic cancer research. These grants facilitate the integration of diverse research capabilities, promoting innovative approaches to cancer prevention, diagnosis, and therapy. CCSGs encourage collaboration among researchers and the development of Shared Resources, ultimately enhancing the understanding of cancer and its treatment. This initiative supports the continuous discovery and dissemination of crucial research findings for community benefit.

The RFA: Biology to Prevention Award (CRUK) aims to foster innovative translational research that enhances understanding of cancer biology, ultimately leading to effective prevention strategies. Joint applications from UK and US research teams are encouraged, with a focus on equal partnerships and complementary expertise. The funding provides up to £600,000 for UK costs and up to $946,000 for US costs, supporting projects of 1 to 5 years duration that address critical research questions in cancer prevention.

The Anna Fuller Fund Grant provides year-round support for organizations dedicated to alleviating suffering caused by cancer. Established in memory of Egbert C. Fuller’s wife, the fund prioritizes applications that focus on cancer research and education initiatives. Eligible applicants must be 501(c)(3) organizations or equivalent charities outside the U.S. Grant funds cannot be used for direct treatment, ensuring that resources are allocated to research and public education.

The James Paul Sutton Medical Research Fund Grant supports non-profit organizations engaged in cancer and medical research, established through a trust by the Sutton family. Eligible organizations must be 501(c)(3) exempt. Preference is given to cancer research initiatives, while grants are not available for individuals, political groups, or for-profit entities. This fund aims to sustain medical research efforts for the long term, continuing the legacy of the Sutton family.

The National Cancer Institute (NCI) plans to issue a Notice of Funding Opportunity (NOFO) for the Paul Calabresi Career Development Award in Clinical Oncology (K12). This program aims to enhance training for clinician-scientists in cancer research, fostering their career development and collaboration with basic research scientists. It mandates diverse oncology specialties in faculty, individualized career development plans, and mentorship, supporting Scholars for up to three years to promote their research initiatives in clinical trials.

The Simeon J. Fortin Charitable Foundation, founded in 1986, champions cancer research initiatives aimed at finding a cure. It supports relevant projects and fellowships within medical and research institutions, ensuring a significant impact on health-related research. The grant review process is conducted by The Medical Foundation, in coordination with the King Trust Postdoctoral Fellowships, enhancing collaboration and funding opportunities for innovative research in oncology.

The AGD Foundation Grant Program supports nonprofit organizations in the U.S. and Canada that provide free oral cancer screenings and education, particularly for underserved communities. Established in 1972, the AGD Foundation aims to enhance public oral health and raise awareness about oral/oropharyngeal cancer. By promoting early detection and education, the foundation seeks to improve survival rates and empower communities. Eligible applicants must be 501(c)(3) organizations demonstrating a commitment to community health.

The EMF SAMFund Financial Assistance Grants support young adult cancer survivors facing financial hardships due to their diagnosis. With 80,000 young adults diagnosed with cancer each year in the U.S., these grants provide critical assistance for essential living expenses like rent, car payments, and education. By prioritizing applicants who demonstrate financial need and articulate how the grant will aid their recovery, the program aims to alleviate financial toxicity and empower survivors to move forward with their lives.

The EMF Family Building Grants, offered by the Expect Miracles Foundation, support young adult cancer survivors in their fertility treatment and family-building efforts. These grants are designed for applicants with a clear family-building plan and financial strategy, helping bridge the gap in costs associated with fertility preservation, assisted reproductive technologies, and related services. By prioritizing those actively engaged in their journey, the foundation aims to empower survivors to pursue their dreams of family.

Individuals being treated for Waldenstrom macroglobulinemia in Wisconsin can apply for HealthWell Foundation’s Waldenstrom Macroglobulinemia Fund; awards up to US $8,000 for prescription drug copays and Medicare Part B premiums. Patients must be underinsured, receiving treatment in the U.S., have insurance covering their medications, and meet income guidelines tied to the Federal Poverty Level.

U.S.-based academic institutions and eligible nonprofits conducting translational cancer research on Fanconi anemia can apply for more than US $135,000 to advance high-risk, high-reward projects. With a mission to end cancer, American Cancer Society and the Fanconi Cancer Foundation support work on FA-related detection, prevention, treatment strategies, and cancer vulnerabilities, including Wisconsin-based researchers.

With a mission to reduce financial barriers to care, Healthwell Foundation provides Wisconsin cancer patients with help paying prescription drug copays and Medicare Part B premiums for mantle cell lymphoma treatment. Underinsured individuals treated in the U.S. who meet income and insurance guidelines may receive up to US $8,500 toward covered medications and biologics.

Patients with chronic lymphocytic leukemia receiving treatment in the U.S., including Wisconsin, can apply for Healthwell Foundation’s copay and premium assistance; awards up to US $8,000 for covered medications. Applicants must have insurance that covers their CLL drugs and meet Healthwell’s income and diagnosis verification requirements.

Individuals in the U.S. with cancer-related behavioral health needs can receive up to US $2,000 to cover prescription copays, counseling, psychotherapy, transportation, and related costs. Healthwell Foundation supports patients, including those in Wisconsin, whose insurance covers part of their treatment but who still face significant out-of-pocket expenses.

Wisconsin cancer and amyloidosis patients can access funding through the HealthWell Foundation for prescription drug copays and Medicare Part B insurance premiums, up to US $8,000. Eligible individuals must be underinsured, receiving amyloidosis treatment in the U.S., have insurance that covers their medication, and meet HealthWell’s income guidelines.

Professional elderly blues musicians facing emergency medical or living expenses can receive US $500 in assistance for care, transportation, utilities, or burial costs across the U.S., including Wisconsin. The Pinetop Perkins Foundation’s PAL program pays creditors directly and may help cancer-focused nonprofits support qualifying artists in crisis.

Grants for research and community organizations in the U.S., including Wisconsin, support patient-centered comparative clinical effectiveness research across the cancer care continuum. Grants from Patient-Centered Outcomes Research Institute help cancer-focused partners study screening barriers, improve evidence-based treatment delivery, and address survivorship and follow-up needs for patients, caregivers, and communities facing high cancer burdens.

Research institutions and healthcare organizations conducting retrospective comparative clinical effectiveness studies in cancer and related conditions in Wisconsin can seek up to US $2,000,000 to inform health decision making and improve outcomes. Patient-Centered Outcomes Research Institute supports methodologically robust, patient-centered projects using existing data sources that address at least one of its priority topic themes.

Cancer research institutions and academic medical centers conducting translational oncology studies can seek funding to advance prevention, early detection, diagnosis, and treatment of human cancers, including work based in Wisconsin. National Institutes of Health SPORE P50 center grants support state-of-the-art, organ-specific or mechanism-based cancer research that reaches a human translational endpoint within the project period.

Graduating high school seniors and healthcare professionals pursuing oncology or hematology education in Central or Southern Illinois can receive tuition or professional development support, including certifications and conferences. Grants from Heart of Illinois Community Foundation help cancer-focused students and practitioners, including those from Macon, Moultrie, or Piatt Counties, advance their training and careers.

Wisconsin cancer and oncology clinician scientists can access funding through the American Society for Radiation Oncology to build independent research careers while maintaining clinical practice. Full-time faculty at U.S. academic institutions or eligible nonprofits in radiation oncology, with clinical licenses and active patient care roles, may be eligible for this clinician scientist development support.

Practicing radiation oncologists in Wisconsin conducting cancer research can apply for the ACS-ASTRO Felix Feng, MD Clinician Scientist Development Award, which provides US $729,000 over three to five years for research across the cancer continuum. This American Society for Radiation Oncology partnership may benefit clinicians affiliated with cancer-focused nonprofits or treatment centers.

Incyte Corporation, a biopharmaceutical leader, offers healthcare sponsorships to support organizations focused on improving patient care and access to healthcare information. Eligible applicants include medical schools, associations, non-profits, advocacy groups, and hospitals. Requests should align with Incyte's commitment to enhancing the lives of patients affected by cancer and other diseases, ensuring compliance with regulatory guidelines. Organizations must enter a written agreement with Incyte to receive funding.

Incyte Corporation invites organizations to submit membership requests aimed at enhancing healthcare access for patients and advocates. As a biopharmaceutical leader, Incyte supports initiatives that align with its mission to improve patient lives through grants and contributions. Eligible entities include medical schools, associations, non-profits, and advocacy groups. Requests should comply with Incyte's regulatory standards and be submitted at least 60 days prior to the required decision date.

The CDC's initiative focuses on developing clinical decision support (CDS) tools for cancer screening and management, specifically for cervical, breast, and colorectal cancers. The project aims to enhance guideline-concordant screening and improve management processes through rigorous implementation and evaluation within large health systems. By integrating these tools into electronic health records, the initiative seeks to support clinicians in making evidence-based decisions at the point of care, ultimately improving patient outcomes in cancer care.

The Health Promotion and Disease Prevention Research Centers are offering supplemental funding for Special Interest Projects (SIPs) aimed at enhancing public health practices. These projects will focus on innovative health promotion and disease prevention strategies to mitigate leading health risks in the U.S. The initiative supports ten specific SIPs, including studies on cancer care, alcohol use reduction, and emergency preparedness, thereby fostering research that translates into real-world health improvements.

The National Cancer Institute (NCI) is set to release a Notice of Funding Opportunity (NOFO) aimed at advancing informatics technologies for cancer research. This initiative will support the development of tools that enhance data acquisition, management, and analysis throughout the cancer continuum. By focusing on technologies with proven impact, the NOFO seeks to optimize and sustain resources critical for cancer biology, diagnosis, treatment, and epidemiology.